Showing results (51-60 of 466) with videos related to
Sort By:
Pageof 47
The Journal of Biological Chemistry|August 25, 1990
DL-3,3-difluoroglutamate: an enhancer of folylpolyglutamate elongationJ J McGuire, W H Haile, P Bey, et al.Biochemical and Biophysical Research Communications|November 30, 1984
Inhibition of growth of Mycoplasma dispar by DL-alpha-difluoromethyllsine, a selective irreversible inhibitor of lysine decarboxylase, and reversal by cadaverine (1,5-diaminopentane)H Pösö, P P McCann, R Tanskanen, et al.The Biochemical Journal|February 15, 1987
Catalytic irreversible inhibition of bacterial and plant arginine decarboxylase activities by novel substrate and product analoguesA J Bitonti, P J Casara, P P McCann, et al.Anti-Cancer Drugs|October 1, 1991
In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiationJ L Merlin, P Chastagner, C Marchal, et al.Annales D'Endocrinologie|January 1, 1986
[Treatment of thyroid ophthalmopathies by external orbital radiotherapy]P Hartemann, J Leclere, P Bey, et al.Journal of Medicinal Chemistry|August 1, 1989
Synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductaseR A Farr, P Bey, P S Sunkara, et al.Bulletin Du Cancer|November 26, 1999
[Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR]C Haie-Meder, B Fervers, J Chauvergne, et al.The Journal of Biological Chemistry|January 5, 1992
Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sitesR Poulin, L Lu, B Ackermann, et al.The American Journal of Pediatric Hematology/Oncology|May 1, 1992
Overview of current treatment of neuroblastomaT PhilipPageof 47